FUTURA MEDICAL PLC Logo

FUTURA MEDICAL PLC

FUM | IL

Overview

Corporate Details

ISIN(s):
GB0033278473
LEI:
21380053QLT46UNV2303
Country:
United Kingdom
Address:
Surrey Technology Centre, GU2 7YG Guildford
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Futura Medical PLC is a pharmaceutical company specializing in the research, development, and global commercialization of innovative sexual health products. The company's core expertise lies in topically delivered gel formulations. Its lead product is Eroxon®, a clinically proven, fast-acting topical treatment for erectile dysfunction (ED) that is available over-the-counter (OTC) without a prescription in major markets, including the USA and Europe. Futura Medical operates a de-risked business model by partnering with established consumer healthcare companies for marketing and distribution. The company's development pipeline includes product extensions and potential treatments for female sexual dysfunction.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for FUTURA MEDICAL PLC. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-08 08:00
Board/Management Information
Board Changes, Business Update & Notice of Results
English 23.1 KB
2025-07-11 12:04
Regulatory News Service
Share price movement
English 11.1 KB
2025-06-20 08:00
Post-Annual General Meeting Information
Result of AGM
English 30.7 KB
2025-06-02 16:15
Regulatory News Service
Block Listing Six Monthly Return
English 18.5 KB
2025-05-27 08:00
Pre-Annual General Meeting Information
Notice of AGM and availability of Annual Report
English 15.9 KB
2025-03-31 08:00
Board/Management Information
Board Appointment
English 18.2 KB
2025-01-30 08:00
Business and Financial Review
FY24 Trading Update and FY25 Outlook
English 28.3 KB
2025-01-13 08:00
Remuneration Information
Remuneration of Non-Executive Directors and TVR's
English 48.6 KB
2024-12-20 08:58
Major Shareholding Notification
Holding(s) in Company
English 52.6 KB
2024-12-02 08:00
Regulatory News Service
Block Listing Six Monthly Return
English 19.6 KB
2024-11-15 08:00
Major Shareholding Notification
TR-1: Notification of major holdings
English 52.6 KB
2024-11-04 08:00
Earnings Release
Encouraging New Product Development Pipeline
English 21.5 KB
2024-10-31 08:00
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
English 12.2 KB
2024-10-17 15:00
Regulatory News Service
Clinical trial data presented at SMSNA
English 15.8 KB
2024-10-07 08:00
Earnings Release
Further milestone payment triggered post US launch
English 12.0 KB

Automate Your Workflow. Get a real-time feed of all FUTURA MEDICAL PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for FUTURA MEDICAL PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Medicofarma Biotech Spolka Akcyjna Logo
Biotech R&D firm developing novel drugs, devices, and therapies with a focus on oncology.
Poland MDB
Medigene AG Logo
An immuno-oncology platform creating T cell receptor (TCR)-guided therapies to treat cancer.
Germany MDG1
MedinCell S.A. Logo
Develops and licenses long-acting injectable therapies using proprietary technology.
France MEDCL
Medivir Logo
Clinical-stage pharma firm developing tumor-directed therapies for high-need cancer patients.
Sweden MVIR
Mendus Logo
Developing immunotherapies using dendritic cells to prevent recurrence of AML & ovarian cancer.
Sweden IMMU
Merck KGaA Logo United States of America 6MK
Sweden MBOLIC
Milton Essex Spolka Akcyjna Logo
Develops AI-powered, non-invasive systems for allergy diagnostics & personalized medicine.
Poland MTN
Modus Therapeutics Holding AB Logo
Clinical-stage biotech developing sevuparin for sepsis, septic shock, and inflammation.
Sweden MODTX
Molecular Partners AG Logo
Pioneering DARPin protein drugs for complex diseases in oncology and virology.
Switzerland MOLN